$140 Million is the total value of EMORY UNIVERSITY's 46 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 36.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRKA | BERKSHIRE HATHAWAY INC DELcl a | $34,995,000 | +0.5% | 117 | 0.0% | 24.99% | -16.4% | |
| JD | Buy | JD COM INCspon adr cl a | $5,041,000 | -2.2% | 124,490 | +0.0% | 3.60% | -18.6% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $3,752,000 | +126.0% | 176,387 | +34.3% | 2.68% | +88.1% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $3,221,000 | +50.1% | 19,170 | -12.7% | 2.30% | +24.9% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $3,069,000 | +50.7% | 46,933 | -7.6% | 2.19% | +25.5% |
| BPMC | New | BLUEPRINT MEDICINES CORP | $2,949,000 | – | 32,163 | +100.0% | 2.11% | – |
| KALA | Buy | KALA PHARMACEUTICALS INC | $2,807,000 | +53.6% | 177,342 | +79.5% | 2.00% | +27.8% |
| AVXS | Buy | AVEXIS INC | $2,777,000 | +35.8% | 22,474 | +21.7% | 1.98% | +13.0% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $2,658,000 | +57.7% | 39,066 | +129.2% | 1.90% | +31.3% |
| ABLX | New | ABLYNX NVsponsored adr | $2,629,000 | – | 48,194 | +100.0% | 1.88% | – |
| IFRX | New | INFLARX NV | $2,618,000 | – | 90,761 | +100.0% | 1.87% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $2,598,000 | – | 16,132 | +100.0% | 1.86% | – |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $2,597,000 | +33.3% | 172,666 | +27.6% | 1.86% | +10.9% |
| RTRX | Buy | RETROPHIN INC | $2,574,000 | +43.9% | 115,136 | +35.6% | 1.84% | +19.7% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $2,548,000 | +31.7% | 30,725 | +23.2% | 1.82% | +9.6% |
| ZGNX | Buy | ZOGENIX INC | $2,543,000 | +30.0% | 63,499 | +30.0% | 1.82% | +8.2% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $2,539,000 | +39.4% | 21,316 | +48.6% | 1.81% | +16.0% |
| INCY | Buy | INCYTE CORP | $2,537,000 | +57.2% | 30,447 | +78.6% | 1.81% | +30.8% |
| AQXP | Buy | AQUINOX PHARMACEUTICALS INC | $2,523,000 | +25.9% | 179,162 | +5.1% | 1.80% | +4.8% |
| SGEN | Buy | SEATTLE GENETICS INC | $2,516,000 | +48.4% | 48,079 | +51.8% | 1.80% | +23.6% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $2,499,000 | +26.6% | 30,823 | +39.2% | 1.78% | +5.4% |
| GHDX | Buy | GENOMIC HEALTH INC | $2,490,000 | +15.7% | 79,591 | +26.5% | 1.78% | -3.7% |
| XLRN | New | ACCELERON PHARMA INC | $2,440,000 | – | 62,410 | +100.0% | 1.74% | – |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $2,429,000 | +21.1% | 21,793 | +29.9% | 1.74% | +0.8% |
| CORI | Buy | CORIUM INTL INC | $2,415,000 | +49.5% | 210,559 | +25.3% | 1.72% | +24.5% |
| STX | Sell | SEAGATE TECHNOLOGY PLC | $2,412,000 | +22.3% | 41,216 | -12.6% | 1.72% | +1.7% |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $2,356,000 | – | 246,411 | +100.0% | 1.68% | – |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $2,337,000 | +16.0% | 101,290 | +23.7% | 1.67% | -3.5% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $2,303,000 | +38.6% | 77,335 | +49.8% | 1.64% | +15.4% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $2,279,000 | +13.6% | 88,462 | +18.9% | 1.63% | -5.5% |
| CBRE | Buy | CBRE GROUP INCcl a | $2,214,000 | +20.9% | 46,888 | +10.9% | 1.58% | +0.6% |
| MSFT | Buy | MICROSOFT CORP | $2,145,000 | +10.7% | 23,505 | +3.8% | 1.53% | -7.9% |
| FOX | Sell | TWENTY FIRST CENTY FOX INCcl b | $2,081,000 | -6.3% | 57,218 | -12.0% | 1.49% | -22.0% |
| MS | Buy | MORGAN STANLEY | $2,076,000 | +4.4% | 38,466 | +1.5% | 1.48% | -13.2% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $2,010,000 | +12.4% | 41,610 | -8.4% | 1.44% | -6.5% |
| TRN | Buy | TRINITY INDS INC | $1,985,000 | -3.5% | 60,831 | +10.8% | 1.42% | -19.7% |
| ESRX | New | EXPRESS SCRIPTS HLDG CO | $1,946,000 | – | 28,172 | +100.0% | 1.39% | – |
| KKR | Buy | KKR & CO L P DEL | $1,935,000 | -2.2% | 95,337 | +1.5% | 1.38% | -18.6% |
| AWI | Sell | ARMSTRONG WORLD INDS INC NEW | $1,928,000 | -11.4% | 34,238 | -4.8% | 1.38% | -26.3% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $1,920,000 | -13.2% | 47,886 | -24.0% | 1.37% | -27.8% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $1,904,000 | -6.7% | 84,714 | +25.0% | 1.36% | -22.3% |
| ADS | Buy | ALLIANCE DATA SYSTEMS CORP | $1,844,000 | -10.2% | 8,662 | +6.9% | 1.32% | -25.3% |
| SMLP | SUMMIT MIDSTREAM PARTNERS LP | $1,230,000 | -31.5% | 87,560 | 0.0% | 0.88% | -43.0% | |
| COCP | New | COCRYSTAL PHARMA INC | $910,000 | – | 152,916 | +100.0% | 0.65% | – |
| AMZN | New | AMAZON COM INC | $229,000 | – | 158 | +100.0% | 0.16% | – |
| SPY | Sell | SPDR S&P 500 ETF TRtr unit | $229,000 | -3.4% | 872 | -1.9% | 0.16% | -19.2% |
| AAPL | Exit | APPLE INC | $0 | – | -1,359 | -100.0% | -0.20% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -518,223 | -100.0% | -1.28% | – |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -602,883 | -100.0% | -1.44% | – |
| TSRO | Exit | TESARO INC | $0 | – | -20,407 | -100.0% | -1.45% | – |
| AAAP | Exit | ADVANCED ACCELERATOR APPLICsponsored ads | $0 | – | -22,538 | -100.0% | -1.58% | – |
| BKR | Exit | BAKER HUGHES A GE COcl a | $0 | – | -58,965 | -100.0% | -1.60% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS | $0 | – | -383,768 | -100.0% | -1.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 23 | Q3 2020 | 71.4% |
| SEATTLE GENETICS INC | 22 | Q2 2019 | 3.7% |
| MORGAN STANLEY | 22 | Q2 2019 | 1.7% |
| VANGUARD INTL EQUITY INDEX F | 18 | Q3 2015 | 100.0% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q2 2019 | 3.3% |
| MICROSOFT CORP | 17 | Q1 2018 | 1.9% |
| CITIGROUP INC | 16 | Q2 2019 | 1.4% |
| GENOMIC HEALTH INC | 15 | Q3 2019 | 3.6% |
| EXPRESS SCRIPTS HLDG CO | 15 | Q1 2018 | 3.8% |
| ACADIA PHARMACEUTICALS INC | 14 | Q2 2019 | 3.8% |
View EMORY UNIVERSITY's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| GeoVax Labs, Inc. | March 29, 2018 | 4,621,405 | 3.5% |
| Geovax Labs, Inc. | October 10, 2006 | 233,905,253 | 33.0% |
View EMORY UNIVERSITY's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-06 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-11 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-09 |
| 13F-HR | 2019-02-12 |
View EMORY UNIVERSITY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.